Anti-Inflammatory Reliever South Africa — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Anti-Inflammatory Reliever South Africa — Stella

Recruiting

Back to Asthma trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

South Africa

Africa Research Health Institute Clinical Trial Unit, Mtubatuba, KwaZulu-Natal

Africa Research Health Institute Clinical Trial Unit, Mtubatuba, KwaZulu-Natal

Key details

Phase

Large-scale testing

Sponsor

University of KwaZulu

Enrollment target

~1,038 participants

Started

June 2024

Primary completion

December 2028

Age range

6 Years – 18 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov